Apolipoprotein B in cardiovascular risk assessment
Canadian Medical Association Journal · 2023
DOI: 10.1503/cmaj.230048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Medical Association Journal, 2023. Verfasst von Maud Ahmad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Schulich School of Medicine and Dentistry (Ahmad, Hegele), Western University, London, Ont.; Mike and Valeria Rosenbloom Centre for Cardiovascular Pr…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cardiovascular System. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Schulich School of Medicine and Dentistry (Ahmad, Hegele), Western University, London, Ont.; Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine (Sniderman), McGill University Health…
Zitieren
APA
Ahmad, M., Sniderman, A. D., & Hegele, R. A. (2023). Apolipoprotein B in cardiovascular risk assessment. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.230048
Vancouver
Ahmad M, Sniderman AD, Hegele RA. Apolipoprotein B in cardiovascular risk assessment. Canadian Medical Association Journal. 2023. doi:10.1503/cmaj.230048
BibTeX
@article{Ahmad2023,
author = {Ahmad, Maud and Sniderman, Allan D and Hegele, Robert A},
title = {Apolipoprotein B in cardiovascular risk assessment},
journal = {Canadian Medical Association Journal},
year = {2023},
doi = {10.1503/cmaj.230048}
}
EUVIMED